

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oligosaccharide catabolic process (GO:0009313) | 5.02473411 |
| 2 | glycosphingolipid catabolic process (GO:0046479) | 4.75563774 |
| 3 | glycolipid catabolic process (GO:0019377) | 4.27391284 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 4.18555709 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.18296732 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.18296732 |
| 7 | COPI coating of Golgi vesicle (GO:0048205) | 3.89246438 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 3.89246438 |
| 9 | protein maturation by protein folding (GO:0022417) | 3.88470170 |
| 10 | mannose metabolic process (GO:0006013) | 3.85943763 |
| 11 | formation of translation preinitiation complex (GO:0001731) | 3.82293862 |
| 12 | ceramide catabolic process (GO:0046514) | 3.81593632 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.67667425 |
| 14 | cell adhesion mediated by integrin (GO:0033627) | 3.67548269 |
| 15 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.64760405 |
| 16 | hyaluronan catabolic process (GO:0030214) | 3.58803962 |
| 17 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.56899562 |
| 18 | regulation of cholesterol esterification (GO:0010872) | 3.55403209 |
| 19 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.54027268 |
| 20 | L-phenylalanine metabolic process (GO:0006558) | 3.54027268 |
| 21 | sphingolipid catabolic process (GO:0030149) | 3.53234137 |
| 22 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.45266028 |
| 23 | membrane lipid catabolic process (GO:0046466) | 3.44583908 |
| 24 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.43496706 |
| 25 | amyloid precursor protein catabolic process (GO:0042987) | 3.40660887 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.36861075 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.34619853 |
| 28 | nucleobase biosynthetic process (GO:0046112) | 3.30859382 |
| 29 | peptide catabolic process (GO:0043171) | 3.29273605 |
| 30 | protein retention in ER lumen (GO:0006621) | 3.28155780 |
| 31 | purine nucleobase biosynthetic process (GO:0009113) | 3.23875947 |
| 32 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.20552362 |
| 33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.17114508 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.16335209 |
| 35 | L-phenylalanine catabolic process (GO:0006559) | 3.16335209 |
| 36 | cellular copper ion homeostasis (GO:0006878) | 3.10723243 |
| 37 | skin morphogenesis (GO:0043589) | 3.10148068 |
| 38 | alpha-linolenic acid metabolic process (GO:0036109) | 3.04403865 |
| 39 | cholesterol efflux (GO:0033344) | 3.03885810 |
| 40 | signal peptide processing (GO:0006465) | 3.03785018 |
| 41 | glucose catabolic process (GO:0006007) | 3.01457338 |
| 42 | phospholipid efflux (GO:0033700) | 3.00007756 |
| 43 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.96018033 |
| 44 | protein carboxylation (GO:0018214) | 2.96018033 |
| 45 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.87716673 |
| 46 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87654620 |
| 47 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87654620 |
| 48 | modulation by symbiont of host immune response (GO:0052553) | 2.87654620 |
| 49 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87654620 |
| 50 | modulation by symbiont of host defense response (GO:0052031) | 2.87654620 |
| 51 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87654620 |
| 52 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.86170145 |
| 53 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.85952800 |
| 54 | toxin transport (GO:1901998) | 2.83068185 |
| 55 | plasma lipoprotein particle assembly (GO:0034377) | 2.82811199 |
| 56 | IMP biosynthetic process (GO:0006188) | 2.81830408 |
| 57 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.81119499 |
| 58 | glucose 6-phosphate metabolic process (GO:0051156) | 2.79125592 |
| 59 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.77734463 |
| 60 | regulation of mononuclear cell migration (GO:0071675) | 2.77195444 |
| 61 | protein targeting to ER (GO:0045047) | 2.76079774 |
| 62 | folic acid transport (GO:0015884) | 2.75291020 |
| 63 | DNA deamination (GO:0045006) | 2.74595275 |
| 64 | cotranslational protein targeting to membrane (GO:0006613) | 2.74013832 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 2.71702348 |
| 66 | folic acid metabolic process (GO:0046655) | 2.70870672 |
| 67 | viral transcription (GO:0019083) | 2.70286641 |
| 68 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.70144212 |
| 69 | COPII vesicle coating (GO:0048208) | 2.68633165 |
| 70 | glycoside metabolic process (GO:0016137) | 2.68208001 |
| 71 | response to interferon-beta (GO:0035456) | 2.67997896 |
| 72 | maturation of SSU-rRNA (GO:0030490) | 2.67134116 |
| 73 | negative regulation of protein activation cascade (GO:2000258) | 2.66785032 |
| 74 | regulation of metalloenzyme activity (GO:0048552) | 2.65937663 |
| 75 | endosome to melanosome transport (GO:0035646) | 2.65205110 |
| 76 | endosome to pigment granule transport (GO:0043485) | 2.65205110 |
| 77 | positive regulation of interferon-alpha production (GO:0032727) | 2.64933396 |
| 78 | regulation of superoxide anion generation (GO:0032928) | 2.62382023 |
| 79 | translational termination (GO:0006415) | 2.61945291 |
| 80 | protein localization to endoplasmic reticulum (GO:0070972) | 2.61489397 |
| 81 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.61371243 |
| 82 | pinocytosis (GO:0006907) | 2.60853065 |
| 83 | sphingosine metabolic process (GO:0006670) | 2.60509060 |
| 84 | apoptotic cell clearance (GO:0043277) | 2.60384666 |
| 85 | * keratan sulfate catabolic process (GO:0042340) | 2.58265669 |
| 86 | plasma lipoprotein particle clearance (GO:0034381) | 2.58121916 |
| 87 | protein-lipid complex assembly (GO:0065005) | 2.57983081 |
| 88 | translational elongation (GO:0006414) | 2.57897686 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.57336043 |
| 90 | basement membrane organization (GO:0071711) | 2.55979705 |
| 91 | fibrinolysis (GO:0042730) | 2.55608628 |
| 92 | regulation of interferon-alpha production (GO:0032647) | 2.54043983 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.52689762 |
| 94 | type B pancreatic cell proliferation (GO:0044342) | 2.52062415 |
| 95 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.50596289 |
| 96 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.50325881 |
| 97 | pentose-phosphate shunt (GO:0006098) | 2.49688078 |
| 98 | vesicle coating (GO:0006901) | 2.48372883 |
| 99 | regulation of protein activation cascade (GO:2000257) | 2.48349404 |
| 100 | IMP metabolic process (GO:0046040) | 2.48124828 |
| 101 | low-density lipoprotein particle clearance (GO:0034383) | 2.47640975 |
| 102 | neutrophil activation involved in immune response (GO:0002283) | 2.47372548 |
| 103 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.47246474 |
| 104 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.47213262 |
| 105 | barbed-end actin filament capping (GO:0051016) | 2.46750950 |
| 106 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.46720870 |
| 107 | positive regulation of B cell differentiation (GO:0045579) | 2.46405541 |
| 108 | amino sugar catabolic process (GO:0046348) | 2.46298828 |
| 109 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.45760166 |
| 110 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.45043159 |
| 111 | translational initiation (GO:0006413) | 2.44662949 |
| 112 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.43726467 |
| 113 | negative regulation of phagocytosis (GO:0050765) | 2.42462538 |
| 114 | membrane protein ectodomain proteolysis (GO:0006509) | 2.42449643 |
| 115 | adhesion of symbiont to host (GO:0044406) | 2.42379053 |
| 116 | amyloid precursor protein metabolic process (GO:0042982) | 2.41002125 |
| 117 | protein localization to endosome (GO:0036010) | 2.39901505 |
| 118 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.39830711 |
| 119 | positive regulation of antigen processing and presentation (GO:0002579) | 2.39530760 |
| 120 | negative regulation of fibrinolysis (GO:0051918) | 2.39421154 |
| 121 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.38967115 |
| 122 | regulation of cholesterol storage (GO:0010885) | 2.38447058 |
| 123 | negative regulation of complement activation (GO:0045916) | 2.38321170 |
| 124 | cellular response to interferon-beta (GO:0035458) | 2.37989736 |
| 125 | B cell mediated immunity (GO:0019724) | 2.37815984 |
| 126 | substrate-dependent cell migration (GO:0006929) | 2.37600499 |
| 127 | regulation of complement activation (GO:0030449) | 2.36074925 |
| 128 | negative regulation of interleukin-12 production (GO:0032695) | 2.35913760 |
| 129 | wound healing, spreading of epidermal cells (GO:0035313) | 2.35708037 |
| 130 | copper ion homeostasis (GO:0055070) | 2.35254834 |
| 131 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.34620537 |
| 132 | actin nucleation (GO:0045010) | 2.31541836 |
| 133 | DNA strand elongation (GO:0022616) | 2.31422735 |
| 134 | lytic vacuole organization (GO:0080171) | 2.31376731 |
| 135 | lysosome organization (GO:0007040) | 2.31376731 |
| 136 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.30950093 |
| 137 | virion attachment to host cell (GO:0019062) | 2.30936344 |
| 138 | adhesion of symbiont to host cell (GO:0044650) | 2.30936344 |
| 139 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.30284305 |
| 140 | macrophage activation involved in immune response (GO:0002281) | 2.29473195 |
| 141 | NADPH regeneration (GO:0006740) | 2.28998061 |
| 142 | leukotriene metabolic process (GO:0006691) | 2.28503737 |
| 143 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.28186461 |
| 144 | cyclooxygenase pathway (GO:0019371) | 2.27869802 |
| 145 | response to thyroid hormone (GO:0097066) | 2.26664519 |
| 146 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.26424183 |
| 147 | glucosamine-containing compound catabolic process (GO:1901072) | 2.26377655 |
| 148 | positive regulation of interferon-beta production (GO:0032728) | 2.26336029 |
| 149 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.26160341 |
| 150 | proline biosynthetic process (GO:0006561) | 2.26140844 |
| 151 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.26052517 |
| 152 | mitotic nuclear envelope disassembly (GO:0007077) | 2.25852891 |
| 153 | decidualization (GO:0046697) | 2.24945339 |
| 154 | vitamin D metabolic process (GO:0042359) | 2.24928546 |
| 155 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.24321380 |
| 156 | low-density lipoprotein particle remodeling (GO:0034374) | 2.23467206 |
| 157 | detection of molecule of bacterial origin (GO:0032490) | 2.22878381 |
| 158 | regulation of integrin activation (GO:0033623) | 2.22420650 |
| 159 | regulation of podosome assembly (GO:0071801) | 2.22087962 |
| 160 | regulation of fibrinolysis (GO:0051917) | 2.20865186 |
| 161 | heme metabolic process (GO:0042168) | 2.20147405 |
| 162 | high-density lipoprotein particle remodeling (GO:0034375) | 2.20060183 |
| 163 | endodermal cell differentiation (GO:0035987) | 2.19783452 |
| 164 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.19288216 |
| 165 | diol metabolic process (GO:0034311) | 2.19080512 |
| 166 | pentose metabolic process (GO:0019321) | 2.19054806 |
| 167 | valine metabolic process (GO:0006573) | 2.17324920 |
| 168 | peptidyl-proline hydroxylation (GO:0019511) | 2.17170120 |
| 169 | viral life cycle (GO:0019058) | 2.16029224 |
| 170 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.15829201 |
| 171 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.15382688 |
| 172 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.15215628 |
| 173 | positive regulation of T cell apoptotic process (GO:0070234) | 2.14935434 |
| 174 | respiratory burst (GO:0045730) | 2.11858274 |
| 175 | response to interferon-alpha (GO:0035455) | 2.11846979 |
| 176 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.11812497 |
| 177 | ribosome biogenesis (GO:0042254) | 2.10849272 |
| 178 | ribosome assembly (GO:0042255) | 2.10821769 |
| 179 | telomere maintenance via recombination (GO:0000722) | 2.10355569 |
| 180 | regulation of antigen processing and presentation (GO:0002577) | 2.09646136 |
| 181 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.09380656 |
| 182 | blood vessel maturation (GO:0001955) | 2.08373542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.64814507 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.04233663 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.72322284 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.21222116 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.73332153 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71280330 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.68550519 |
| 8 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53660613 |
| 9 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41339798 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.24489812 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.22981274 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.14509962 |
| 13 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.10569019 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.05928114 |
| 15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.03901382 |
| 16 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.99817496 |
| 17 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.98899069 |
| 18 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.97145443 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.94526854 |
| 20 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93220870 |
| 21 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.93079876 |
| 22 | MYC_22102868_ChIP-Seq_BL_Human | 1.91897627 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91689213 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.90238762 |
| 25 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.90130898 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88629609 |
| 27 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.87391869 |
| 28 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.86131828 |
| 29 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.85659721 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84882990 |
| 31 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.83987318 |
| 32 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.83292899 |
| 33 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.82994489 |
| 34 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79974410 |
| 35 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79316023 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.79307432 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.77871307 |
| 38 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75004393 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.74892767 |
| 40 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.74080242 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73391777 |
| 42 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73113593 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72324385 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67952962 |
| 45 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.67536908 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.67494652 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65674868 |
| 48 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65640019 |
| 49 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.64582347 |
| 50 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.63869308 |
| 51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.62043844 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.61974562 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61523484 |
| 54 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.60606110 |
| 55 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59567734 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.57138792 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.56796555 |
| 58 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56183731 |
| 59 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.55740477 |
| 60 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54375201 |
| 61 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53450336 |
| 62 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.49349139 |
| 63 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.48747913 |
| 64 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.48579558 |
| 65 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47548195 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44245685 |
| 67 | GATA1_22025678_ChIP-Seq_K562_Human | 1.43587950 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42615833 |
| 69 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.41569919 |
| 70 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.41482591 |
| 71 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.41371028 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40928565 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.39787532 |
| 74 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.37429737 |
| 75 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36641246 |
| 76 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.35878455 |
| 77 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35309580 |
| 78 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35112112 |
| 79 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31068015 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.29993370 |
| 81 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.29767098 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29671949 |
| 83 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.26484262 |
| 84 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.26484262 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.26234689 |
| 86 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26126037 |
| 87 | MYB_26560356_Chip-Seq_TH2_Human | 1.25531673 |
| 88 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25321381 |
| 89 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25051047 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.24262772 |
| 91 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24160666 |
| 92 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24061095 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23346708 |
| 94 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21058039 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20223372 |
| 96 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.19972904 |
| 97 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17117601 |
| 98 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.16941739 |
| 99 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16557699 |
| 100 | MAF_26560356_Chip-Seq_TH1_Human | 1.15382123 |
| 101 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.15065863 |
| 102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14459813 |
| 103 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.14223631 |
| 104 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.14037095 |
| 105 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13229450 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13183229 |
| 107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.12362660 |
| 108 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.12340475 |
| 109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12317166 |
| 110 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.12218608 |
| 111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12024741 |
| 112 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11258112 |
| 113 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11226874 |
| 114 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10312804 |
| 115 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10235987 |
| 116 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.10231799 |
| 117 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.09389480 |
| 118 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08958582 |
| 119 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08831724 |
| 120 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.07801538 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07231977 |
| 122 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.06822188 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06428159 |
| 124 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.05755274 |
| 125 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.05640856 |
| 126 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05494606 |
| 127 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04652109 |
| 128 | MYB_26560356_Chip-Seq_TH1_Human | 1.04611834 |
| 129 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.03803031 |
| 130 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03146423 |
| 131 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.02644085 |
| 132 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01835917 |
| 133 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.01822600 |
| 134 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.01699142 |
| 135 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.01228097 |
| 136 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00397631 |
| 137 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99292376 |
| 138 | * SPI1_23127762_ChIP-Seq_K562_Human | 0.99120430 |
| 139 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98833567 |
| 140 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.98624507 |
| 141 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98495509 |
| 142 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.98342913 |
| 143 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97665955 |
| 144 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.97407517 |
| 145 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95989800 |
| 146 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.95632201 |
| 147 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95263955 |
| 148 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95027089 |
| 149 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.94058712 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.91120519 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.26111274 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 2.87062917 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.46597839 |
| 5 | MP0003172_abnormal_lysosome_physiology | 2.27681728 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.24956889 |
| 7 | MP0003693_abnormal_embryo_hatching | 2.21813385 |
| 8 | MP0002254_reproductive_system_inflammat | 2.20403535 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.15204695 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.11209921 |
| 11 | MP0003300_gastrointestinal_ulcer | 2.10526654 |
| 12 | MP0005257_abnormal_intraocular_pressure | 2.10100866 |
| 13 | MP0005365_abnormal_bile_salt | 2.08015325 |
| 14 | MP0000604_amyloidosis | 1.97187994 |
| 15 | MP0003436_decreased_susceptibility_to | 1.93038851 |
| 16 | MP0009840_abnormal_foam_cell | 1.91503061 |
| 17 | MP0005451_abnormal_body_composition | 1.81869627 |
| 18 | MP0010307_abnormal_tumor_latency | 1.77772534 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.77558656 |
| 20 | MP0006054_spinal_hemorrhage | 1.75654073 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.75320253 |
| 22 | MP0000490_abnormal_crypts_of | 1.73213525 |
| 23 | * MP0002419_abnormal_innate_immunity | 1.70214639 |
| 24 | MP0000685_abnormal_immune_system | 1.68642776 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.67303283 |
| 26 | MP0003724_increased_susceptibility_to | 1.65588807 |
| 27 | MP0003941_abnormal_skin_development | 1.63242652 |
| 28 | MP0003195_calcinosis | 1.58927146 |
| 29 | MP0005408_hypopigmentation | 1.58038417 |
| 30 | MP0001790_abnormal_immune_system | 1.56793957 |
| 31 | MP0005387_immune_system_phenotype | 1.56793957 |
| 32 | MP0005025_abnormal_response_to | 1.56719233 |
| 33 | * MP0002452_abnormal_antigen_presenting | 1.54360628 |
| 34 | MP0004957_abnormal_blastocyst_morpholog | 1.53913551 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.53035987 |
| 36 | MP0005464_abnormal_platelet_physiology | 1.50425378 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.50022089 |
| 38 | MP0006082_CNS_inflammation | 1.49669346 |
| 39 | MP0000858_altered_metastatic_potential | 1.49626445 |
| 40 | MP0008007_abnormal_cellular_replicative | 1.48994380 |
| 41 | MP0009278_abnormal_bone_marrow | 1.46126632 |
| 42 | MP0009643_abnormal_urine_homeostasis | 1.45918013 |
| 43 | MP0009785_altered_susceptibility_to | 1.45887249 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.44814136 |
| 45 | MP0005023_abnormal_wound_healing | 1.44724915 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.43453454 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.42038279 |
| 48 | MP0005397_hematopoietic_system_phenotyp | 1.42038279 |
| 49 | MP0001756_abnormal_urination | 1.40141432 |
| 50 | MP0002148_abnormal_hypersensitivity_rea | 1.38637199 |
| 51 | * MP0001819_abnormal_immune_cell | 1.35486682 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.35413086 |
| 53 | * MP0002420_abnormal_adaptive_immunity | 1.35073565 |
| 54 | MP0001800_abnormal_humoral_immune | 1.34345305 |
| 55 | MP0003111_abnormal_nucleus_morphology | 1.34265234 |
| 56 | MP0000343_altered_response_to | 1.33896608 |
| 57 | MP0003448_altered_tumor_morphology | 1.33574575 |
| 58 | MP0003329_amyloid_beta_deposits | 1.33447873 |
| 59 | MP0005671_abnormal_response_to | 1.33366922 |
| 60 | MP0003186_abnormal_redox_activity | 1.31792218 |
| 61 | MP0008004_abnormal_stomach_pH | 1.31154622 |
| 62 | MP0002723_abnormal_immune_serum | 1.30380380 |
| 63 | MP0003075_altered_response_to | 1.29246987 |
| 64 | * MP0000689_abnormal_spleen_morphology | 1.28924299 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.27545234 |
| 66 | MP0001958_emphysema | 1.26683652 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.25644110 |
| 68 | MP0005165_increased_susceptibility_to | 1.24402799 |
| 69 | MP0005360_urolithiasis | 1.23877828 |
| 70 | MP0002405_respiratory_system_inflammati | 1.22982386 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.21609934 |
| 72 | MP0005085_abnormal_gallbladder_physiolo | 1.20683687 |
| 73 | MP0004264_abnormal_extraembryonic_tissu | 1.20494609 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.20210135 |
| 75 | MP0001666_abnormal_nutrient_absorption | 1.18861501 |
| 76 | * MP0002398_abnormal_bone_marrow | 1.18804923 |
| 77 | MP0004272_abnormal_basement_membrane | 1.18690806 |
| 78 | * MP0002722_abnormal_immune_system | 1.18072593 |
| 79 | MP0000465_gastrointestinal_hemorrhage | 1.17080529 |
| 80 | MP0005310_abnormal_salivary_gland | 1.15895785 |
| 81 | MP0002136_abnormal_kidney_physiology | 1.15297074 |
| 82 | MP0002295_abnormal_pulmonary_circulatio | 1.14800083 |
| 83 | * MP0000716_abnormal_immune_system | 1.14393753 |
| 84 | MP0010386_abnormal_urinary_bladder | 1.14184895 |
| 85 | MP0003950_abnormal_plasma_membrane | 1.13634222 |
| 86 | * MP0002429_abnormal_blood_cell | 1.13157832 |
| 87 | MP0003077_abnormal_cell_cycle | 1.11277923 |
| 88 | MP0002877_abnormal_melanocyte_morpholog | 1.11255404 |
| 89 | MP0002060_abnormal_skin_morphology | 1.10971532 |
| 90 | MP0005503_abnormal_tendon_morphology | 1.10562810 |
| 91 | MP0001873_stomach_inflammation | 1.10459969 |
| 92 | MP0003303_peritoneal_inflammation | 1.08780719 |
| 93 | MP0005164_abnormal_response_to | 1.08453605 |
| 94 | MP0010329_abnormal_lipoprotein_level | 1.08427114 |
| 95 | MP0001243_abnormal_dermal_layer | 1.08391726 |
| 96 | MP0008469_abnormal_protein_level | 1.07611806 |
| 97 | MP0004947_skin_inflammation | 1.05037822 |
| 98 | MP0005275_abnormal_skin_tensile | 1.05035006 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 1.04776201 |
| 100 | MP0003183_abnormal_peptide_metabolism | 1.04479223 |
| 101 | MP0001849_ear_inflammation | 1.04162354 |
| 102 | MP0002090_abnormal_vision | 1.03753442 |
| 103 | MP0008875_abnormal_xenobiotic_pharmacok | 1.00074448 |
| 104 | MP0003279_aneurysm | 0.99401175 |
| 105 | MP0002006_tumorigenesis | 0.98708802 |
| 106 | MP0005174_abnormal_tail_pigmentation | 0.96189280 |
| 107 | MP0002019_abnormal_tumor_incidence | 0.95664232 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.94801429 |
| 109 | MP0003795_abnormal_bone_structure | 0.94526689 |
| 110 | MP0010094_abnormal_chromosome_stability | 0.91920752 |
| 111 | MP0005390_skeleton_phenotype | 0.91535213 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.91378126 |
| 113 | MP0003091_abnormal_cell_migration | 0.90904584 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.90768549 |
| 115 | MP0003763_abnormal_thymus_physiology | 0.90347040 |
| 116 | MP0003866_abnormal_defecation | 0.90325844 |
| 117 | MP0001542_abnormal_bone_strength | 0.90118659 |
| 118 | MP0000609_abnormal_liver_physiology | 0.89272359 |
| 119 | MP0000358_abnormal_cell_content/ | 0.88260303 |
| 120 | MP0004019_abnormal_vitamin_homeostasis | 0.87274075 |
| 121 | * MP0002135_abnormal_kidney_morphology | 0.86804699 |
| 122 | MP0003122_maternal_imprinting | 0.84961460 |
| 123 | MP0001853_heart_inflammation | 0.83655535 |
| 124 | MP0001915_intracranial_hemorrhage | 0.83421818 |
| 125 | MP0000371_diluted_coat_color | 0.82816788 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.82300269 |
| 127 | MP0005332_abnormal_amino_acid | 0.82299655 |
| 128 | MP0003656_abnormal_erythrocyte_physiolo | 0.80765799 |
| 129 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80764240 |
| 130 | MP0001216_abnormal_epidermal_layer | 0.80601023 |
| 131 | MP0001764_abnormal_homeostasis | 0.80510231 |
| 132 | * MP0000598_abnormal_liver_morphology | 0.79655056 |
| 133 | MP0009384_cardiac_valve_regurgitation | 0.78905438 |
| 134 | MP0010368_abnormal_lymphatic_system | 0.78481774 |
| 135 | MP0005367_renal/urinary_system_phenotyp | 0.78098758 |
| 136 | MP0000516_abnormal_urinary_system | 0.78098758 |
| 137 | MP0002933_joint_inflammation | 0.77247480 |
| 138 | MP0009764_decreased_sensitivity_to | 0.76108236 |
| 139 | MP0001661_extended_life_span | 0.75968921 |
| 140 | MP0002098_abnormal_vibrissa_morphology | 0.75867738 |
| 141 | MP0004147_increased_porphyrin_level | 0.74889050 |
| 142 | MP0001730_embryonic_growth_arrest | 0.73610974 |
| 143 | MP0008260_abnormal_autophagy | 0.73323609 |
| 144 | MP0000767_abnormal_smooth_muscle | 0.70863277 |
| 145 | MP0004883_abnormal_blood_vessel | 0.68907671 |
| 146 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.68774931 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.68337499 |
| 148 | MP0010678_abnormal_skin_adnexa | 0.68171981 |
| 149 | MP0002118_abnormal_lipid_homeostasis | 0.67735684 |
| 150 | MP0000537_abnormal_urethra_morphology | 0.63731771 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Vacuolated lymphocytes (HP:0001922) | 4.95666542 |
| 2 | Dysostosis multiplex (HP:0000943) | 4.68967575 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 3.91771515 |
| 4 | * Urinary glycosaminoglycan excretion (HP:0003541) | 3.68873719 |
| 5 | * Mucopolysacchariduria (HP:0008155) | 3.68873719 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.66428383 |
| 7 | Petechiae (HP:0000967) | 3.48526858 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47938234 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.41952865 |
| 10 | Thrombocytosis (HP:0001894) | 3.40534427 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.40080569 |
| 12 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.30674136 |
| 13 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.30674136 |
| 14 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.30674136 |
| 15 | * Cervical subluxation (HP:0003308) | 3.16904855 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.00767010 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.00767010 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.00767010 |
| 19 | Abnormal gallbladder physiology (HP:0012438) | 2.97247017 |
| 20 | Cholecystitis (HP:0001082) | 2.97247017 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.93976687 |
| 22 | Nuclear cataract (HP:0100018) | 2.93180726 |
| 23 | IgM deficiency (HP:0002850) | 2.80991430 |
| 24 | Myocardial infarction (HP:0001658) | 2.78951178 |
| 25 | Prolonged neonatal jaundice (HP:0006579) | 2.75107441 |
| 26 | Deep venous thrombosis (HP:0002625) | 2.74320364 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 2.73889296 |
| 28 | Pustule (HP:0200039) | 2.73321529 |
| 29 | * Abnormality of macrophages (HP:0004311) | 2.68219485 |
| 30 | Reticulocytopenia (HP:0001896) | 2.67564510 |
| 31 | * Progressive neurologic deterioration (HP:0002344) | 2.65907777 |
| 32 | Vascular calcification (HP:0004934) | 2.64754451 |
| 33 | Mitral stenosis (HP:0001718) | 2.62572257 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.61964150 |
| 35 | Cardiovascular calcification (HP:0011915) | 2.59568994 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54107796 |
| 37 | Aplastic anemia (HP:0001915) | 2.46878150 |
| 38 | Amyloidosis (HP:0011034) | 2.46859837 |
| 39 | Myositis (HP:0100614) | 2.46395771 |
| 40 | Xanthomatosis (HP:0000991) | 2.45292580 |
| 41 | Abnormality of the common coagulation pathway (HP:0010990) | 2.43746560 |
| 42 | Hand muscle atrophy (HP:0009130) | 2.42143552 |
| 43 | Poor head control (HP:0002421) | 2.40381183 |
| 44 | Loss of speech (HP:0002371) | 2.38235793 |
| 45 | Agnosia (HP:0010524) | 2.37595910 |
| 46 | Ankle contracture (HP:0006466) | 2.36424877 |
| 47 | Protrusio acetabuli (HP:0003179) | 2.35948812 |
| 48 | Spondylolisthesis (HP:0003302) | 2.35811422 |
| 49 | Hepatosplenomegaly (HP:0001433) | 2.32459457 |
| 50 | Complement deficiency (HP:0004431) | 2.30866554 |
| 51 | Vertebral compression fractures (HP:0002953) | 2.28392316 |
| 52 | Intrahepatic cholestasis (HP:0001406) | 2.26523682 |
| 53 | Osteolytic defects of the hand bones (HP:0009699) | 2.25978486 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.25978486 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.25006724 |
| 56 | * Ovoid vertebral bodies (HP:0003300) | 2.24117281 |
| 57 | Interstitial pulmonary disease (HP:0006530) | 2.23022316 |
| 58 | * Joint stiffness (HP:0001387) | 2.22482233 |
| 59 | Gingival bleeding (HP:0000225) | 2.20961505 |
| 60 | Hypokinesia (HP:0002375) | 2.19518603 |
| 61 | Autoimmune thrombocytopenia (HP:0001973) | 2.16464297 |
| 62 | Metaphyseal irregularity (HP:0003025) | 2.14837205 |
| 63 | Abnormality of the anterior horn cell (HP:0006802) | 2.13661070 |
| 64 | Degeneration of anterior horn cells (HP:0002398) | 2.13661070 |
| 65 | Multiple enchondromatosis (HP:0005701) | 2.12843422 |
| 66 | Rough bone trabeculation (HP:0100670) | 2.11029463 |
| 67 | Abnormality of complement system (HP:0005339) | 2.10026533 |
| 68 | Bone pain (HP:0002653) | 2.09807571 |
| 69 | Persistence of primary teeth (HP:0006335) | 2.04657411 |
| 70 | Neurofibrillary tangles (HP:0002185) | 2.04386336 |
| 71 | Chronic otitis media (HP:0000389) | 2.03850163 |
| 72 | Abnormal delivery (HP:0001787) | 2.02789588 |
| 73 | Tetraparesis (HP:0002273) | 2.01796580 |
| 74 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.00039822 |
| 75 | Asymmetric septal hypertrophy (HP:0001670) | 1.99798574 |
| 76 | Esophageal neoplasm (HP:0100751) | 1.99770463 |
| 77 | Neoplasm of head and neck (HP:0012288) | 1.99770463 |
| 78 | Upper motor neuron abnormality (HP:0002127) | 1.99189469 |
| 79 | Premature rupture of membranes (HP:0001788) | 1.98765553 |
| 80 | J-shaped sella turcica (HP:0002680) | 1.98095441 |
| 81 | Generalized aminoaciduria (HP:0002909) | 1.97607077 |
| 82 | Nausea (HP:0002018) | 1.96457850 |
| 83 | Abnormal platelet function (HP:0011869) | 1.94708256 |
| 84 | Impaired platelet aggregation (HP:0003540) | 1.94708256 |
| 85 | Arterial thrombosis (HP:0004420) | 1.94669208 |
| 86 | Glomerulonephritis (HP:0000099) | 1.93894103 |
| 87 | Hypoalphalipoproteinemia (HP:0003233) | 1.91153612 |
| 88 | Gout (HP:0001997) | 1.88647419 |
| 89 | Diminished motivation (HP:0000745) | 1.87635972 |
| 90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.87352291 |
| 91 | Apathy (HP:0000741) | 1.87275533 |
| 92 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85972818 |
| 93 | Thin bony cortex (HP:0002753) | 1.85906483 |
| 94 | Protuberant abdomen (HP:0001538) | 1.85855261 |
| 95 | Thoracic kyphosis (HP:0002942) | 1.84695743 |
| 96 | Polyuria (HP:0000103) | 1.84226933 |
| 97 | Pathologic fracture (HP:0002756) | 1.84223234 |
| 98 | Spinal muscular atrophy (HP:0007269) | 1.82549204 |
| 99 | Type I transferrin isoform profile (HP:0003642) | 1.82193891 |
| 100 | Increased serum ferritin (HP:0003281) | 1.82184719 |
| 101 | Skin nodule (HP:0200036) | 1.81112604 |
| 102 | Vascular tortuosity (HP:0004948) | 1.80753792 |
| 103 | Atrophic scars (HP:0001075) | 1.80703710 |
| 104 | Recurrent viral infections (HP:0004429) | 1.80661653 |
| 105 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80617518 |
| 106 | Disinhibition (HP:0000734) | 1.80277667 |
| 107 | Abnormal trabecular bone morphology (HP:0100671) | 1.79013815 |
| 108 | Axonal loss (HP:0003447) | 1.78969713 |
| 109 | Increased CSF protein (HP:0002922) | 1.78507476 |
| 110 | Hyperammonemia (HP:0001987) | 1.77928409 |
| 111 | * Beaking of vertebral bodies (HP:0004568) | 1.77896503 |
| 112 | Recurrent fungal infections (HP:0002841) | 1.77848086 |
| 113 | Hypolipoproteinemia (HP:0010981) | 1.77629668 |
| 114 | Gingivitis (HP:0000230) | 1.76907818 |
| 115 | Short nail (HP:0001799) | 1.75961771 |
| 116 | Orchitis (HP:0100796) | 1.75657412 |
| 117 | Cutaneous melanoma (HP:0012056) | 1.75410420 |
| 118 | Proximal tubulopathy (HP:0000114) | 1.75355674 |
| 119 | Aortic dissection (HP:0002647) | 1.74245882 |
| 120 | Abnormality of carpal bone ossification (HP:0006257) | 1.73998864 |
| 121 | Joint hemorrhage (HP:0005261) | 1.73934562 |
| 122 | Enlarged penis (HP:0000040) | 1.73658476 |
| 123 | Arterial tortuosity (HP:0005116) | 1.73012875 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.72495453 |
| 125 | Steatorrhea (HP:0002570) | 1.72495395 |
| 126 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.71214974 |
| 127 | Cardiomegaly (HP:0001640) | 1.71175173 |
| 128 | Abnormality of the lumbar spine (HP:0100712) | 1.69509677 |
| 129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.68729832 |
| 130 | Abnormal urine output (HP:0012590) | 1.68660514 |
| 131 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68420006 |
| 132 | Blue sclerae (HP:0000592) | 1.68229816 |
| 133 | * Abnormality of the acetabulum (HP:0003170) | 1.67920768 |
| 134 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.67890487 |
| 135 | Wrist flexion contracture (HP:0001239) | 1.67830288 |
| 136 | Fatigue (HP:0012378) | 1.67329838 |
| 137 | Hypophosphatemic rickets (HP:0004912) | 1.66834342 |
| 138 | Microretrognathia (HP:0000308) | 1.66798119 |
| 139 | Fat malabsorption (HP:0002630) | 1.65820485 |
| 140 | Purpura (HP:0000979) | 1.65538420 |
| 141 | Prolonged partial thromboplastin time (HP:0003645) | 1.65262747 |
| 142 | Right ventricular cardiomyopathy (HP:0011663) | 1.63627787 |
| 143 | Retinal atrophy (HP:0001105) | 1.63135513 |
| 144 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.61916547 |
| 145 | 11 pairs of ribs (HP:0000878) | 1.61471048 |
| 146 | Abnormal number of erythroid precursors (HP:0012131) | 1.61254408 |
| 147 | Upper limb amyotrophy (HP:0009129) | 1.60674060 |
| 148 | Distal upper limb amyotrophy (HP:0007149) | 1.60674060 |
| 149 | Cellulitis (HP:0100658) | 1.60243409 |
| 150 | Microglossia (HP:0000171) | 1.59412396 |
| 151 | Hematochezia (HP:0002573) | 1.59375047 |
| 152 | Emphysema (HP:0002097) | 1.59204775 |
| 153 | Reduced antithrombin III activity (HP:0001976) | 1.59013397 |
| 154 | Carpal bone hypoplasia (HP:0001498) | 1.58643962 |
| 155 | Prolonged bleeding time (HP:0003010) | 1.57254849 |
| 156 | Abnormal protein glycosylation (HP:0012346) | 1.56518439 |
| 157 | Abnormal glycosylation (HP:0012345) | 1.56518439 |
| 158 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.56518439 |
| 159 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.56518439 |
| 160 | Abnormality of T cell physiology (HP:0011840) | 1.55952596 |
| 161 | Hyperglycinuria (HP:0003108) | 1.55754147 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK2 | 3.10412280 |
| 2 | NME2 | 2.99964682 |
| 3 | MAP3K12 | 2.95279987 |
| 4 | EEF2K | 2.58034542 |
| 5 | ERN1 | 2.56314257 |
| 6 | SCYL2 | 2.55612430 |
| 7 | CCNB1 | 2.53041363 |
| 8 | TRIB3 | 2.32167992 |
| 9 | KIT | 2.31802288 |
| 10 | MAP4K1 | 2.31312121 |
| 11 | WEE1 | 2.14926453 |
| 12 | PIM2 | 2.09055128 |
| 13 | PBK | 1.94533698 |
| 14 | PKN2 | 1.94248437 |
| 15 | FLT3 | 1.93787601 |
| 16 | MYLK | 1.85138326 |
| 17 | TGFBR2 | 1.84758063 |
| 18 | BLK | 1.82161680 |
| 19 | TYK2 | 1.81267634 |
| 20 | ZAP70 | 1.77474211 |
| 21 | PAK4 | 1.70093619 |
| 22 | EPHB2 | 1.68526267 |
| 23 | LRRK2 | 1.66363130 |
| 24 | LIMK1 | 1.63137798 |
| 25 | FER | 1.62125015 |
| 26 | BUB1 | 1.61404000 |
| 27 | TSSK6 | 1.61260936 |
| 28 | EIF2AK1 | 1.55496201 |
| 29 | EIF2AK3 | 1.53236937 |
| 30 | RPS6KA4 | 1.52461206 |
| 31 | DDR2 | 1.50191486 |
| 32 | JAK3 | 1.49852506 |
| 33 | EPHA2 | 1.49770945 |
| 34 | BCKDK | 1.48542053 |
| 35 | EPHB1 | 1.48440870 |
| 36 | RIPK1 | 1.45872104 |
| 37 | MAPKAPK3 | 1.41732623 |
| 38 | EPHA3 | 1.41304026 |
| 39 | STK16 | 1.40708498 |
| 40 | ABL2 | 1.40001522 |
| 41 | NEK9 | 1.38747258 |
| 42 | TAOK3 | 1.37359375 |
| 43 | MAP3K3 | 1.37041874 |
| 44 | PTK2 | 1.36827929 |
| 45 | TBK1 | 1.35442365 |
| 46 | CSF1R | 1.31279330 |
| 47 | BTK | 1.30817840 |
| 48 | BRSK2 | 1.28952315 |
| 49 | IRAK3 | 1.28278612 |
| 50 | NEK2 | 1.28159269 |
| 51 | TAOK2 | 1.27264984 |
| 52 | STK10 | 1.25531157 |
| 53 | MST1R | 1.23945581 |
| 54 | TESK2 | 1.20786187 |
| 55 | GRK7 | 1.19790563 |
| 56 | TGFBR1 | 1.19514060 |
| 57 | FGFR4 | 1.19330869 |
| 58 | MAP2K3 | 1.19093618 |
| 59 | MATK | 1.17011762 |
| 60 | TRPM7 | 1.15965222 |
| 61 | LMTK2 | 1.13851151 |
| 62 | TEC | 1.13417703 |
| 63 | RPS6KB2 | 1.13048170 |
| 64 | TESK1 | 1.12218454 |
| 65 | PDGFRA | 1.09979181 |
| 66 | NEK1 | 1.09321069 |
| 67 | FGR | 1.04844690 |
| 68 | ADRBK2 | 1.04253002 |
| 69 | PASK | 1.00501559 |
| 70 | IRAK4 | 0.96779719 |
| 71 | CLK1 | 0.95620284 |
| 72 | CDC42BPA | 0.94470146 |
| 73 | PIK3CA | 0.94386194 |
| 74 | PIM1 | 0.91098507 |
| 75 | MST4 | 0.90277777 |
| 76 | WNK3 | 0.90201703 |
| 77 | SIK3 | 0.89025251 |
| 78 | MOS | 0.87405959 |
| 79 | KDR | 0.85372454 |
| 80 | PTK6 | 0.83946752 |
| 81 | IKBKB | 0.83743933 |
| 82 | CSNK1G3 | 0.83354919 |
| 83 | DYRK3 | 0.82893543 |
| 84 | MAP2K2 | 0.82590402 |
| 85 | MAP3K8 | 0.81204012 |
| 86 | MAP3K11 | 0.77039218 |
| 87 | SYK | 0.76161297 |
| 88 | MAP3K2 | 0.75234425 |
| 89 | PRKG2 | 0.73398639 |
| 90 | CAMKK2 | 0.72263770 |
| 91 | NTRK1 | 0.69823365 |
| 92 | CSNK1G1 | 0.69393386 |
| 93 | ACVR1B | 0.67173337 |
| 94 | NLK | 0.66754014 |
| 95 | JAK1 | 0.65881594 |
| 96 | CSNK1A1L | 0.65375368 |
| 97 | GRK6 | 0.64758595 |
| 98 | INSRR | 0.64361865 |
| 99 | LYN | 0.63550393 |
| 100 | CDK4 | 0.63526898 |
| 101 | MET | 0.63080204 |
| 102 | ZAK | 0.61419952 |
| 103 | ARAF | 0.59947198 |
| 104 | CDK7 | 0.59876645 |
| 105 | ATR | 0.59024114 |
| 106 | YES1 | 0.58874185 |
| 107 | MAP3K14 | 0.58761127 |
| 108 | TXK | 0.58735513 |
| 109 | MAP3K1 | 0.58042674 |
| 110 | LCK | 0.57713715 |
| 111 | TRIM28 | 0.55258853 |
| 112 | BMX | 0.55058635 |
| 113 | AURKB | 0.54127278 |
| 114 | DAPK3 | 0.53864225 |
| 115 | DAPK1 | 0.53703833 |
| 116 | CDC7 | 0.53182121 |
| 117 | IRAK1 | 0.53066987 |
| 118 | ERBB4 | 0.50351182 |
| 119 | MAP3K10 | 0.49623729 |
| 120 | RPS6KA2 | 0.49612353 |
| 121 | PAK1 | 0.49133542 |
| 122 | LATS2 | 0.49019477 |
| 123 | ILK | 0.48867127 |
| 124 | ROCK2 | 0.46898818 |
| 125 | RPS6KA6 | 0.45808174 |
| 126 | PAK2 | 0.45787398 |
| 127 | VRK1 | 0.45597806 |
| 128 | JAK2 | 0.45595794 |
| 129 | SIK1 | 0.45151762 |
| 130 | RPS6KC1 | 0.44589693 |
| 131 | RPS6KL1 | 0.44589693 |
| 132 | PLK1 | 0.44555964 |
| 133 | GSK3A | 0.43883723 |
| 134 | ITK | 0.43596550 |
| 135 | MAPKAPK2 | 0.43406182 |
| 136 | CSK | 0.43191407 |
| 137 | HCK | 0.43128267 |
| 138 | CDK6 | 0.42085554 |
| 139 | FGFR3 | 0.40524964 |
| 140 | FRK | 0.39818381 |
| 141 | ERBB3 | 0.39173837 |
| 142 | PDPK1 | 0.37283342 |
| 143 | ABL1 | 0.35516123 |
| 144 | MAP2K6 | 0.35072977 |
| 145 | CSNK1G2 | 0.32748110 |
| 146 | STK38 | 0.32405958 |
| 147 | LATS1 | 0.32209328 |
| 148 | CDK8 | 0.31257504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Other glycan degradation_Homo sapiens_hsa00511 | 3.59775854 |
| 2 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.98922971 |
| 3 | * Lysosome_Homo sapiens_hsa04142 | 2.92264186 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.70139074 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.49060916 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.48784844 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.24095573 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.14946128 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.07211597 |
| 10 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.06619001 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.03709355 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.03645936 |
| 13 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.00495087 |
| 14 | Mismatch repair_Homo sapiens_hsa03430 | 1.89543714 |
| 15 | Legionellosis_Homo sapiens_hsa05134 | 1.88403119 |
| 16 | Protein export_Homo sapiens_hsa03060 | 1.83087227 |
| 17 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77166248 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.65268889 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.63728323 |
| 20 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.57411077 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.53367349 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.50002531 |
| 23 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47127727 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.46921231 |
| 25 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.45841939 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43267187 |
| 27 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42004469 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.40621360 |
| 29 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.36178697 |
| 30 | RNA polymerase_Homo sapiens_hsa03020 | 1.32567358 |
| 31 | Pertussis_Homo sapiens_hsa05133 | 1.32225463 |
| 32 | RNA transport_Homo sapiens_hsa03013 | 1.30994752 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.27632459 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26186540 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23858994 |
| 36 | * Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.23290812 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.23289869 |
| 38 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21136040 |
| 39 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.20337134 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19740324 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18474022 |
| 42 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15178867 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.11640119 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.11296245 |
| 45 | Apoptosis_Homo sapiens_hsa04210 | 1.09552269 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 1.07718417 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.06961379 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.04897378 |
| 49 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04808929 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.04071853 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.03521882 |
| 52 | Measles_Homo sapiens_hsa05162 | 1.03317890 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.00767015 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00724553 |
| 55 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99635152 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.98747212 |
| 57 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98555032 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.97666904 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 0.97540251 |
| 60 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95713061 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94728350 |
| 62 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92499689 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92102066 |
| 64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91441067 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90703473 |
| 66 | Spliceosome_Homo sapiens_hsa03040 | 0.90554919 |
| 67 | * Galactose metabolism_Homo sapiens_hsa00052 | 0.90096323 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.87946126 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87084946 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.85978240 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.85794178 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85586978 |
| 73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83070942 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.81286960 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80078568 |
| 76 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79009941 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.78839695 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78281069 |
| 79 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.77346638 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76630103 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76007963 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75605136 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74730800 |
| 84 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73712892 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73480899 |
| 86 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.73075661 |
| 87 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72034252 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.71720779 |
| 89 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.71714933 |
| 90 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71660897 |
| 91 | Hepatitis B_Homo sapiens_hsa05161 | 0.71399305 |
| 92 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71157311 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.71069941 |
| 94 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.69789811 |
| 95 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69729568 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69598444 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.68676118 |
| 98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67946517 |
| 99 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66103535 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66081830 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.65851013 |
| 102 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.65639993 |
| 103 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64943278 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64310227 |
| 105 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.63932061 |
| 106 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62746708 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62631261 |
| 108 | Asthma_Homo sapiens_hsa05310 | 0.59940503 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.59819230 |
| 110 | Prion diseases_Homo sapiens_hsa05020 | 0.59780752 |
| 111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59642297 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58920365 |
| 113 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58568568 |
| 114 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58286843 |
| 115 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58223897 |
| 116 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57876859 |
| 117 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.55507169 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.54214464 |
| 119 | Mineral absorption_Homo sapiens_hsa04978 | 0.54009622 |
| 120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.53996471 |
| 121 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.52569071 |
| 122 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52429259 |
| 123 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.51194515 |
| 124 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51072908 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.50529156 |
| 126 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47549261 |
| 127 | Bladder cancer_Homo sapiens_hsa05219 | 0.46673324 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.46539213 |
| 129 | Salmonella infection_Homo sapiens_hsa05132 | 0.45600023 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45565982 |
| 131 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44839640 |
| 132 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44717771 |
| 133 | Purine metabolism_Homo sapiens_hsa00230 | 0.43388218 |
| 134 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.42918055 |
| 135 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42881075 |
| 136 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42874034 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.42828913 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.42522523 |
| 139 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.42129179 |
| 140 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39221626 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38510684 |
| 142 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.38502230 |
| 143 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.37811350 |
| 144 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37060470 |
| 145 | * Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.37057324 |
| 146 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32603602 |
| 147 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32478097 |
| 148 | Adherens junction_Homo sapiens_hsa04520 | 0.31256215 |
| 149 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.30706578 |
| 150 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30420740 |

